Hepatic and extrahepatic reduction of nicotine 1'-N-oxide in rats.
作者信息
Dajani R M, Gorrod J W, Beckett A H
出版信息
Biochem J. 1972 Nov;130(2):88P. doi: 10.1042/bj1300088p.
Abstract
摘要
相似文献
1
Hepatic and extrahepatic reduction of nicotine 1'-N-oxide in rats.
Biochem J. 1972 Nov;130(2):88P. doi: 10.1042/bj1300088p.
2
In vitro hepatic and extra-hepatic reduction of (minus)-nicotine-1'-N-oxide in rats.大鼠体内（-）-尼古丁-1'-N-氧化物的体外肝脏和肝外还原作用
Biochem Pharmacol. 1975 Jan 1;24(1):109-17. doi: 10.1016/0006-2952(75)90322-6.
3
Selective inhibition of alternative oxidative pathways of nicotine metabolism.尼古丁代谢旁路氧化途径的选择性抑制。
Chem Biol Interact. 1971 Aug;3(4):269-70. doi: 10.1016/0009-2797(71)90056-1.
4
Factors affecting the in vitro metabolism of R-(+)- and S-(-)-nicotine by guinea-pig liver preparations.豚鼠肝脏制剂对R-(+)-和S-(-)-尼古丁体外代谢的影响因素。
Xenobiotica. 1973 Sep;3(9):563-72. doi: 10.3109/00498257309151544.
5
Absorption of (-)-nicotine-l-N-oxide in man and its reduction in the gastrointestinal tract.
J Pharm Pharmacol. 1970 Sep;22(9):722-3. doi: 10.1111/j.2042-7158.1970.tb12767.x.
6
[On 2-benzolsulfonylamino-5 (beta-methoxyethoxy) pyrimidine (Glycodiazin). VII. On the mechanism of demethylation of Glycodiazin].[关于2-苯磺酰氨基-5（β-甲氧基乙氧基）嘧啶（格列嘧啶）。VII. 格列嘧啶的去甲基化机制]
Arzneimittelforschung. 1968 Jun;18(6):704-12.
7
Reduction in vivo of (minus)-nicotine-1'-N-oxide by germ-free and conventional rats.
Biochem Pharmacol. 1975 Mar 1;24(5):648-50. doi: 10.1016/0006-2952(75)90189-6.
8
Species and substrate differences of liver microsomal N-dealkylation and N-oxidation of tertiary amines and N-dealkylation of N-oxides.肝脏微粒体中叔胺的N-脱烷基化和N-氧化以及N-氧化物的N-脱烷基化的物种和底物差异。
Xenobiotica. 1971 Jul-Oct;1(4):533-4. doi: 10.3109/00498257109041522.
9
Oxidative metabolism of aflatoxin B1 by rat liver microsomes in vitro and its effect on lipid peroxidation.黄曲霉毒素B1在大鼠肝脏微粒体中的体外氧化代谢及其对脂质过氧化的影响。
Res Commun Chem Pathol Pharmacol. 1974 Aug;8(4):703-6.
10
Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.肝微粒体中还原型三磷酸吡啶核苷酸依赖性混合功能氧化酶系统的二磷酸吡啶核苷酸协同作用降低。II. 细胞色素P-450 I型药物结合位点的作用。
Mol Pharmacol. 1973 Jul;9(4):470-85.
本文引用的文献
1
Enzymic oxidation of (-)-nicotine by guinea-pig tissues in vitro.豚鼠组织在体外对（-）-尼古丁的酶促氧化作用。
Biochem Pharmacol. 1971 Feb;20(2):407-15. doi: 10.1016/0006-2952(71)90075-x.
2
The analysis of nicotine-1'-N-oxide in urine, in the presence of nicotine and cotinine, and its application to the study of in vivo nicotine metabolism in man.
J Pharm Pharmacol. 1971 Dec;23:55S-61S. doi: 10.1111/j.2042-7158.1971.tb08769.x.
3
Absorption of (-)-nicotine-l-N-oxide in man and its reduction in the gastrointestinal tract.
J Pharm Pharmacol. 1970 Sep;22(9):722-3. doi: 10.1111/j.2042-7158.1970.tb12767.x.
Zotero 插件